Indeed, we observed a tendency of reduced level of acetylated cortactin (AcCTTN) upon CXCL12 treatment in murine CLL cells with intact NEDD9 (Fig. 6B, C, left). The gene discussed is CXCL12; the disease is B-cell chronic lymphocytic leukemia.